Top

Published in:

01-07-2013 | META-ANALYSIS

A meta-analysis of prospective studies of coffee consumption and mortality for all causes, cancers and cardiovascular diseases

Published in: European Journal of Epidemiology | Issue 7/2013

Abstract

Several prospective studies considered the relation between coffee consumption and mortality. Most studies, however, were underpowered to detect an association, since they included relatively few deaths. To obtain quantitative overall estimates, we combined all published data from prospective studies on the relation of coffee with mortality for all causes, all cancers, cardiovascular disease (CVD), coronary/ischemic heart disease (CHD/IHD) and stroke. A bibliography search, updated to January 2013, was carried out in PubMed and Embase to identify prospective observational studies providing quantitative estimates on mortality from all causes, cancer, CVD, CHD/IHD or stroke in relation to coffee consumption. A systematic review and meta-analysis was conducted to estimate overall relative risks (RR) and 95 % confidence intervals (CI) using random-effects models. The pooled RRs of all cause mortality for the study-specific highest versus low (≤1 cup/day) coffee drinking categories were 0.88 (95 % CI 0.84–0.93) based on all the 23 studies, and 0.87 (95 % CI 0.82–0.93) for the 19 smoking adjusting studies. The combined RRs for CVD mortality were 0.89 (95 % CI 0.77–1.02, 17 smoking adjusting studies) for the highest versus low drinking and 0.98 (95 % CI 0.95–1.00, 16 studies) for the increment of 1 cup/day. Compared with low drinking, the RRs for the highest consumption of coffee were 0.95 (95 % CI 0.78–1.15, 12 smoking adjusting studies) for CHD/IHD, 0.95 (95 % CI 0.70–1.29, 6 studies) for stroke, and 1.03 (95 % CI 0.97–1.10, 10 studies) for all cancers. This meta-analysis provides quantitative evidence that coffee intake is inversely related to all cause and, probably, CVD mortality.

Available only for authorised users

Ferruzzi MG. The influence of beverage composition on delivery of phenolic compounds from coffee and tea. Physiol Behav. 2010;100(1):33–41. doi:10.1016/j.physbeh.2010.01.035.PubMedCrossRef

Huxley R, Lee CM, Barzi F, et al. Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch Intern Med. 2009;169(22):2053–63. doi:10.1001/archinternmed.2009.439.PubMedCrossRef

Larsson SC, Orsini N. Coffee consumption and risk of stroke: a dose-response meta-analysis of prospective studies. Am J Epidemiol. 2011;174(9):993–1001. doi:10.1093/aje/kwr226.PubMedCrossRef

Bravi F, Bosetti C, Tavani A, et al. Coffee drinking and hepatocellular carcinoma risk: a meta-analysis. Hepatology. 2007;46(2):430–5. doi:10.1002/hep.21708.PubMedCrossRef

Bravi F, Scotti L, Bosetti C, et al. Coffee drinking and endometrial cancer risk: a metaanalysis of observational studies. Am J Obstet Gynecol. 2009;200(2):130–5. doi:10.1016/j.ajog.2008.10.032.PubMedCrossRef

Je Y, Liu W, Giovannucci E. Coffee consumption and risk of colorectal cancer: a systematic review and meta-analysis of prospective cohort studies. Int J Cancer. 2009;124(7):1662–8. doi:10.1002/ijc.24124.PubMedCrossRef

Galeone C, Tavani A, Pelucchi C, et al. Coffee and tea intake and risk of head and neck cancer: pooled analysis in the international head and neck cancer epidemiology consortium. Cancer Epidemiol Biomarkers Prev. 2010;19(7):1723–36. doi:10.1158/1055-9965.EPI-10-0191.PubMedCrossRef

Turati F, Galeone C, La Vecchia C, Garavello W, Tavani A. Coffee and cancers of the upper digestive and respiratory tracts: meta-analyses of observational studies. Ann Oncol. 2011;22(3):536–44. doi:10.1093/annonc/mdq603.PubMedCrossRef

Dawber TR, Kannel WB, Gordon T. Coffee and cardiovascular disease. Observations from the framingham study. N Engl J Med. 1974;291(17):871–4. doi:10.1056/NEJM197410242911703.PubMedCrossRef

10.

Heyden S, Tyroler HA, Heiss G, Hames CG, Bartel A. Coffee consumption and mortality. Total mortality, stroke mortality, and coronary heart disease mortality. Arch Intern Med. 1978;138(10):1472–5.PubMedCrossRef

11.

Murray SS, Bjelke E, Gibson RW, Schuman LM. Coffee consumption and mortality from ischemic heart disease and other causes: results from the Lutheran Brotherhood study, 1966-1978. Am J Epidemiol. 1981;113(6):661–7.PubMed

12.

Jacobsen BK, Bjelke E, Kvale G, Heuch I. Coffee drinking, mortality, and cancer incidence: results from a Norwegian prospective study. J Natl Cancer Inst. 1986;76(5):823–31.PubMed

13.

Vandenbroucke JP, Kok FJ, van ‘t Bosch G, van den Dungen PJ, van der Heide-Wessel C, van der Heide RM. Coffee drinking and mortality in a 25-year follow up. Am J Epidemiol. 1986;123(2):359–61.PubMed

14.

LeGrady D, Dyer AR, Shekelle RB, et al. Coffee consumption and mortality in the Chicago Western Electric Company Study. Am J Epidemiol. 1987;126(5):803–12.PubMed

15.

Rosengren A, Wilhelmsen L. Coffee, coronary heart disease and mortality in middle-aged Swedish men: findings from the Primary Prevention Study. J Intern Med. 1991;230(1):67–71.PubMedCrossRef

16.

Lindsted KD, Kuzma JW, Anderson JL. Coffee consumption and cause-specific mortality. Association with age at death and compression of mortality. J Clin Epidemiol. 1992;45(7):733–42. doi:10.1016/0895-4356(92)90051-N.PubMedCrossRef

17.

Klatsky AL, Armstrong MA, Friedman GD. Coffee, tea, and mortality. Ann Epidemiol. 1993;3(4):375–81.PubMedCrossRef

18.

Woodward M, Tunstall-Pedoe H. Coffee and tea consumption in the Scottish Heart Health Study follow up: conflicting relations with coronary risk factors, coronary disease, and all cause mortality. J Epidemiol Community Health. 1999;53(8):481–7.PubMedCrossRef

19.

Kleemola P, Jousilahti P, Pietinen P, Vartiainen E, Tuomilehto J. Coffee consumption and the risk of coronary heart disease and death. Arch Intern Med. 2000;160(22):3393–400. doi:10.1001/archinte.160.22.3393.PubMedCrossRef

20.

Iwai N, Ohshiro H, Kurozawa Y, et al. Relationship between coffee and green tea consumption and all-cause mortality in a cohort of a rural Japanese population. J Epidemiol. 2002;12(3):191–8.PubMedCrossRef

21.

Jazbec A, Simic D, Corovic N, Durakovic Z, Pavlovic M. Impact of coffee and other selected factors on general mortality and mortality due to cardiovascular disease in Croatia. J Health Popul Nutr. 2003;21(4):332–40.PubMed

22.

Andersen LF, Jacobs DR Jr, Carlsen MH, Blomhoff R. Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women’s Health Study. Am J Clin Nutr. 2006;83(5):1039–46.PubMed

23.

Iso H, Kubota Y. Nutrition and disease in the Japan Collaborative Cohort Study for Evaluation of Cancer (JACC). Asian Pac J Cancer Prev. 2007;8(Suppl):35–80.PubMed

24.

Paganini-Hill A, Kawas CH, Corrada MM. Non-alcoholic beverage and caffeine consumption and mortality: the Leisure World Cohort Study. Prev Med. 2007;44(4):305–10. doi:10.1016/j.ypmed.2006.12.011.PubMedCrossRef

25.

Happonen P, Laara E, Hiltunen L, Luukinen H. Coffee consumption and mortality in a 14-year follow-up of an elderly northern Finnish population. Br J Nutr. 2008;99(6):1354–61. doi:10.1017/S0007114507871650.PubMedCrossRef

26.

Laaksonen M, Talala K, Martelin T, et al. Health behaviours as explanations for educational level differences in cardiovascular and all-cause mortality: a follow-up of 60 000 men and women over 23 years. Eur J Public Health. 2008;18(1):38–43. doi:10.1093/eurpub/ckm051.PubMedCrossRef

27.

Lopez-Garcia E, van Dam RM, Li TY, Rodriguez-Artalejo F, Hu FB. The relationship of coffee consumption with mortality. Ann Intern Med. 2008;148(12):904–14. doi:10.7326/0003-4819-148-12-200806170-00003.PubMedCrossRef

28.

Ahmed HN, Levitan EB, Wolk A, Mittleman MA. Coffee consumption and risk of heart failure in men: an analysis from the Cohort of Swedish Men. Am Heart J. 2009;158(4):667–72. doi:10.1016/j.ahj.2009.07.006.PubMedCrossRef

29.

de Koning Gans JM, Uiterwaal CS, van der Schouw YT, et al. Tea and coffee consumption and cardiovascular morbidity and mortality. Arterioscler Thromb Vasc Biol. 2010;30(8):1665–71. doi:10.1161/ATVBAHA.109.201939.

30.

Sugiyama K, Kuriyama S, Akhter M, et al. Coffee consumption and mortality due to all causes, cardiovascular disease, and cancer in Japanese women. J Nutr. 2010;140(5):1007–13. doi:10.3945/jn.109.109314.PubMedCrossRef

31.

Tamakoshi A, Lin Y, Kawado M, Yagyu K, Kikuchi S, Iso H. Effect of coffee consumption on all-cause and total cancer mortality: findings from the JACC study. Eur J Epidemiol. 2011;26(4):285–93. doi:10.1007/s10654-011-9548-7.PubMedCrossRef

32.

Freedman ND, Park Y, Abnet CC, Hollenbeck AR, Sinha R. Association of coffee drinking with total and cause-specific mortality. N Engl J Med. 2012;366(20):1891–904. doi:10.1056/NEJMoa1112010.PubMedCrossRef

33.

Nilsson LM, Winkvist A, Brustad M, et al. A traditional Sami diet score as a determinant of mortality in a general northern Swedish population. Int J Circumpolar Health. 2012;71:1–12. doi:10.3402/ijch.v71i0.18537.PubMed

34.

Heyden S, Heyden F, Heiss G, Hames CG. Smoking and coffee consumption in three groups: cancer deaths, cardiovascular deaths and living controls. A prospective study in Evans County, Georgia. J Chronic Dis. 1979;32(9–10):673–7.PubMedCrossRef

35.

Tverdal A, Stensvold I, Solvoll K, Foss OP, Lund-Larsen P, Bjartveit K. Coffee consumption and death from coronary heart disease in middle aged Norwegian men and women. BMJ. 1990;300(6724):566–9.PubMedCrossRef

36.

Stensvold I, Tverdal A, Jacobsen BK. Cohort study of coffee intake and death from coronary heart disease over 12 years. BMJ. 1996;312(7030):544–5.PubMedCrossRef

37.

Hart C, Smith GD. Coffee consumption and coronary heart disease mortality in Scottish men: a 21 year follow up study. J Epidemiol Community Health. 1997;51(4):461–2.PubMedCrossRef

38.

Greenberg JA, Chow G, Ziegelstein RC. Caffeinated coffee consumption, cardiovascular disease, and heart valve disease in the elderly (from the Framingham Study). Am J Cardiol. 2008;102(11):1502–8. doi:10.1016/j.amjcard.2008.07.046.PubMedCrossRef

39.

Leurs LJ, Schouten LJ, Goldbohm RA, van den Brandt PA. Total fluid and specific beverage intake and mortality due to IHD and stroke in the Netherlands Cohort Study. Br J Nutr. 2010;104(8):1212–21. doi:10.1017/S0007114510001923.PubMedCrossRef

40.

Mineharu Y, Koizumi A, Wada Y, et al. Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women. J Epidemiol Community Health. 2011;65(3):230–40. doi:10.1136/jech.2009.097311.PubMedCrossRef

41.

Khan MM, Goto R, Kobayashi K, et al. Dietary habits and cancer mortality among middle aged and older Japanese living in hokkaido, Japan by cancer site and sex. Asian Pac J Cancer Prev. 2004;5(1):58–65.PubMed

42.

Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–12. doi:10.1001/jama.283.15.2008.PubMedCrossRef

43.

Greenberg JA, Dunbar CC, Schnoll R, Kokolis R, Kokolis S, Kassotis J. Caffeinated beverage intake and the risk of heart disease mortality in the elderly: a prospective analysis. Am J Clin Nutr. 2007;85(2):392–8.PubMed

44.

Paganini-Hill A. Lifestyle practices and cardiovascular disease mortality in the elderly: the leisure world cohort study. Cardiol Res Pract. 2011;2011:983764. doi:10.4061/2011/983764.PubMed

45.

Heyden S, Tyroler HA, Cassel JC, Hames CG, Becker C, Heiss G. Coffee consumption and mortality in a community study–Evans Co., Ga. Z Ernahrungswiss. 1976;15(2):143–50.PubMedCrossRef

46.

Snowdon DA, Phillips RL. Coffee consumption and risk of fatal cancers. Am J Public Health. 1984;74(8):820–3.PubMedCrossRef

47.

Fortes C, Forastiere F, Farchi S, Rapiti E, Pastori G, Perucci CA. Diet and overall survival in a cohort of very elderly people. Epidemiology. 2000;11(4):440–5.PubMedCrossRef

48.

Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 1992;135(11):1301–9.PubMed

49.

Hamling J, Lee P, Weitkunat R, Ambuhl M. Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category. Stat Med. 2008;27(7):954–70. doi:10.1002/sim.3013.PubMedCrossRef

50.

Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60. doi:10.1136/bmj.327.7414.557.PubMedCrossRef

51.

Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–101.PubMedCrossRef

52.

Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.PubMedCrossRef

53.

Wu JN, Ho SC, Zhou C, et al. Coffee consumption and risk of coronary heart diseases: a meta-analysis of 21 prospective cohort studies. Int J Cardiol. 2009;137(3):216–25. doi:10.1016/j.ijcard.2008.06.051.PubMedCrossRef

54.

Larsson SC, Mannisto S, Virtanen MJ, Kontto J, Albanes D, Virtamo J. Coffee and tea consumption and risk of stroke subtypes in male smokers. Stroke. 2008;39(6):1681–7. doi:10.1161/STROKEAHA.107.504183.PubMedCrossRef

55.

Larsson SC, Virtamo J, Wolk A. Coffee consumption and risk of stroke in women. Stroke. 2011;42(4):908–12. doi:10.1161/STROKEAHA.110.603787.PubMedCrossRef

56.

Lopez-Garcia E, Rodriguez-Artalejo F, Rexrode KM, Logroscino G, Hu FB, van Dam RM. Coffee consumption and risk of stroke in women. Circulation. 2009;119(8):1116–23. doi:10.1161/CIRCULATIONAHA.108.826164.PubMedCrossRef

57.

James JE. Is habitual caffeine use a preventable cardiovascular risk factor? Lancet. 1997;349(9047):279–81. doi:10.1016/S0140-6736(96)04253-5.PubMedCrossRef

58.

Zhang Z, Hu G, Caballero B, Appel L, Chen L. Habitual coffee consumption and risk of hypertension: a systematic review and meta-analysis of prospective observational studies. Am J Clin Nutr. 2011;93(6):1212–9. doi:10.3945/ajcn.110.004044.PubMedCrossRef

59.

Mesas AE, Leon-Munoz LM, Rodriguez-Artalejo F, Lopez-Garcia E. The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: a systematic review and meta-analysis. Am J Clin Nutr. 2011;94(4):1113–26. doi:10.3945/ajcn.111.016667.PubMedCrossRef

60.

Thelle DS, Arnesen E, Forde OH. The Tromso heart study. Does coffee raise serum cholesterol? N Engl J Med. 1983;308(24):1454–7. doi:10.1056/NEJM198306163082405.PubMedCrossRef

61.

D’Avanzo B, Santoro L, Nobill A, La Vecchia C. Coffee consumption and serum cholesterol. GISSI-EFRIM Study Group. Prev Med. 1993;22(2):219–24.PubMedCrossRef

62.

Jee SH, He J, Appel LJ, Whelton PK, Suh I, Klag MJ. Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol. 2001;153(4):353–62.PubMedCrossRef

63.

Cai L, Ma D, Zhang Y, Liu Z, Wang P. The effect of coffee consumption on serum lipids: a meta-analysis of randomized controlled trials. Eur J Clin Nutr. 2012;66(8):872–7. doi:10.1038/ejcn.2012.68.PubMedCrossRef

64.

Zhang W, Lopez-Garcia E, Li TY, Hu FB, van Dam RM. Coffee consumption and risk of cardiovascular diseases and all-cause mortality among men with type 2 diabetes. Diabetes Care. 2009;32(6):1043–5. doi:10.2337/dc08-2251.PubMedCrossRef

65.

Zhang WL, Lopez-Garcia E, Li TY, Hu FB, van Dam RM. Coffee consumption and risk of cardiovascular events and all-cause mortality among women with type 2 diabetes. Diabetologia. 2009;52(5):810–7. doi:10.1007/s00125-009-1311-1.PubMedCrossRef

66.

Montagnana M, Favaloro EJ, Lippi G. Coffee intake and cardiovascular disease: virtue does not take center stage. Semin Thromb Hemost. 2012;38(2):164–77. doi:10.1055/s-0032-1301414.PubMedCrossRef

67.

Choi HK, Willett W, Curhan G. Coffee consumption and risk of incident gout in men: a prospective study. Arthritis Rheum. 2007;56(6):2049–55. doi:10.1002/art.22712.PubMedCrossRef

68.

Imatoh T, Tanihara S, Miyazaki M, Momose Y, Uryu Y, Une H. Coffee consumption but not green tea consumption is associated with adiponectin levels in Japanese males. Eur J Nutr. 2011;50(4):279–84. doi:10.1007/s00394-010-0136-5.PubMedCrossRef

69.

Kempf K, Herder C, Erlund I, et al. Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial. Am J Clin Nutr. 2010;91(4):950–7. doi:10.3945/ajcn.2009.28548.PubMedCrossRef

70.

Mostofsky E, Rice MS, Levitan EB, Mittleman MA. Habitual coffee consumption and risk of heart failure: a dose-response meta-analysis. Circ Heart Fail. 2012;5(4):401–5. doi:10.1161/CIRCHEARTFAILURE.112.967299.PubMedCrossRef

71.

Pelchovitz DJ, Goldberger JJ. Caffeine and cardiac arrhythmias: a review of the evidence. Am J Med. 2011;124(4):284–9. doi:10.1016/j.amjmed.2010.10.017.PubMedCrossRef

72.

Svilaas A, Sakhi AK, Andersen LF, et al. Intakes of antioxidants in coffee, wine, and vegetables are correlated with plasma carotenoids in humans. J Nutr. 2004;134(3):562–7.PubMed

73.

Kawachi I, Willett WC, Colditz GA, Stampfer MJ, Speizer FE. A prospective study of coffee drinking and suicide in women. Arch Intern Med. 1996;156(5):521–5.PubMedCrossRef

74.

Yu X, Bao Z, Zou J, Dong J. Coffee consumption and risk of cancers: a meta-analysis of cohort studies. BMC Cancer. 2011;11:96. doi:10.1186/1471-2407-11-96.PubMedCrossRef

75.

Galeone C, Turati F, La Vecchia C, Tavani A. Coffee consumption and risk of colorectal cancer: a meta-analysis of case-control studies. Cancer Causes Control. 2010;21(11):1949–59. doi:10.1007/s10552-010-9623-5.PubMedCrossRef

76.

Zhang X, Albanes D, Beeson WL, et al. Risk of colon cancer and coffee, tea, and sugar-sweetened soft drink intake: pooled analysis of prospective cohort studies. J Natl Cancer Inst. 2010;102(11):771–83. doi:10.1093/jnci/djq107.PubMedCrossRef

77.

Viani R. The composition of coffee. In: Garattini S, editor. Caffeine, coffee, and health. New York: Raven Press; 1993. p. 17–41.

78.

D’Avanzo B, La Vecchia C, Katsouyanni K, Negri E, Trichopoulos D. An assessment, and reproducibility of food frequency data provided by hospital controls. Eur J Cancer Prev. 1997;6(3):288–93.PubMedCrossRef

79.

Ferraroni M, Tavani A, Decarli A, et al. Reproducibility and validity of coffee and tea consumption in Italy. Eur J Clin Nutr. 2004;58(4):674–80. doi:10.1038/sj.ejcn.1601864.PubMedCrossRef

80.

Cornelis MC, El-Sohemy A, Kabagambe EK, Campos H. Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA. 2006;295(10):1135–41. doi:10.1001/jama.295.10.1135.PubMedCrossRef

81.

Istvan J, Matarazzo JD. Tobacco, alcohol, and caffeine use: a review of their interrelationships. Psychol Bull. 1984;95(2):301–26.PubMedCrossRef

82.

IARC. Coffee, tea, mate, methylxanthines and methylglyoxal. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 27 February to 6 March 1990. IARC Monogr Eval Carcinog Risks Hum. 1991;51:1–513.

Title: A meta-analysis of prospective studies of coffee consumption and mortality for all causes, cancers and cardiovascular diseases
Publication date: 01-07-2013
Published in: European Journal of Epidemiology / Issue 7/2013
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI: https://doi.org/10.1007/s10654-013-9834-7

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

A meta-analysis of prospective studies of coffee consumption and mortality for all causes, cancers and cardiovascular diseases

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 7/2013

Better risk assessment with glycated hemoglobin instead of cholesterol in CVD risk prediction charts

Clinical depression, antidepressant use and risk of future cardiovascular disease

Serum calcium and the calcium-sensing receptor polymorphism rs17251221 in relation to coronary heart disease, type 2 diabetes, cancer and mortality: the Tromsø Study

Influenza H1N1 vaccination and adverse pregnancy outcome

Circulating 25-hydroxyvitamin D levels and hypertension risk

Risk categorization for calculating net reclassification improvement